These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6685363)

  • 1. [A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis].
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Ugeskr Laeger; 1983 Jul; 145(30):2302-3. PubMed ID: 6685363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].
    Tymiński W; Czestochowska E; Swiecicki P
    Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936
    [No Abstract]   [Full Text] [Related]  

  • 3. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Scand J Haematol; 1982 Sep; 29(3):217-23. PubMed ID: 6890710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasminogen variant Chicago III.
    Wohl RC; Summaria L; Chediak J; Rosenfeld S; Robbins KC
    Thromb Haemost; 1982 Oct; 48(2):146-52. PubMed ID: 6217576
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA; de Boer A; Colucci M; Jonker JJ; Collen D
    Thromb Haemost; 1985 Oct; 54(3):725. PubMed ID: 3937271
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent thrombosis of the superior vena cava associated with activated protein C resistance: imaging findings.
    Provenzale JM; Frush DP; Ortel TL
    Pediatr Radiol; 1998 Aug; 28(8):597-8. PubMed ID: 9716630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
    Hach-Wunderle V; Scharrer I
    Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasminogen activator but normal prostacyclin activity in rat veins during development of experimental thrombosis.
    Mysliwiec M; Villa S; Kornblihtt L; de Gaetano G; Donati MB
    Thromb Res; 1980 Apr 1-15; 18(1-2):159-65. PubMed ID: 6996209
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.
    Isacson S; Nilsson IM
    Acta Chir Scand; 1972; 138(4):313-9. PubMed ID: 5040598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Decreased fibrinolytic activity in venous walls of patients with venous thromboses].
    Hach V; Heyland H; Walter-Fincke R; Scharrer I
    Vasa; 1985; 14(4):336-9. PubMed ID: 4072368
    [No Abstract]   [Full Text] [Related]  

  • 11. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clot lysis activity of plasminogen activator isolated from human tissue].
    Matsuo O
    Rinsho Byori; 1982 Jun; Suppl 50():167-77. PubMed ID: 6890121
    [No Abstract]   [Full Text] [Related]  

  • 13. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombomodulin, plasminogen activator and plasminogen activator inhibitor levels in preterm infants with or without respiratory distress syndrome.
    Yurdakök M; Yigit S
    Acta Paediatr; 1997 Sep; 86(9):1022-3. PubMed ID: 9343292
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activator activity of superficial veins in acute deep venous thrombosis.
    Ljungnér H; Bergqvist D; Isacson S
    Vasa; 1982; 11(3):174-7. PubMed ID: 6890278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-directed thrombolysis for deep venous thrombosis.
    Raju S; Fountain T; McPherson SH
    J Miss State Med Assoc; 1998 Mar; 39(3):81-4. PubMed ID: 9538591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases].
    Czestochowska E
    Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesenteric vein thrombosis and vascular plasminogen activator.
    Boyko OB; Pizzo SV
    Arch Pathol Lab Med; 1983 Oct; 107(10):541-2. PubMed ID: 6688517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.